Linde
NASDAQ: LIN
$512.42 ▲ +6.10  (+1.20%)
At close: Jul 24, 2026 · 3:59 PM UTC
Financial Ratios
Market Cap237.95 Bn
P/E33.52
P/S6.87
Div. Yield0.01
ROIC (Qtr)0.00
Total Debt (Qtr)24.68 Bn
Revenue Growth (1y) (Qtr)8.25
Add ratio to table…

About

Linde plc is the largest industrial gas company worldwide and a major technological innovator in the industrial gases industry. Its primary products include atmospheric gases such as oxygen, nitrogen, argon, and rare gases, and process gases such as hydrogen, helium, carbon dioxide, carbon monoxide, electronic gases, specialty gases, and acetylene. The company also designs and builds equipment that produces industrial gases and offers customers a wide range of gas production…

Read more ↓
Sector: Basic Materials Industry: Specialty Chemicals CIK: 0001707925

Investment Thesis

▲ Bull case
  • Linde plc's electronics segment presents a significant growth catalyst that the market is underestimating, with management indicating high confidence in adding substantial new projects to the $7.1 billion sale-of-gas backlog this year. The company is investing over $1 billion in ultra-high-purity plants to support advanced semiconductor fabrication, positioning itself as a critical enabler for AI-driven chip demand in key regions like the US, China, and Korea. Given the sector's industrial gas intensity and scale expansion, Linde's strategic focus on securing long-term contracts with major and emerging launch providers for space and semiconductor applications creates a structural tailwind beyond temporary cyclical recovery. This backlog growth potential, combined with the electronics segment's 10% year-over-year sales increase, suggests upside to EPS guidance that excludes helium upside and assumes no economic improvement, as incremental project wins could drive volume and margin expansion in high-margin, technology-intensive end markets.
  • The helium business represents an unappreciated source of incremental earnings power, with 85%-90% of sales contractually locked and management prioritizing long-term agreements amid acute global shortages. Despite current guidance excluding any helium upside, CFO Matthew White explicitly stated he would "fully anticipate" pricing to continue rising throughout the year and roll through the contractual business, with excess molecules enabling pursuit of new multiyear contracts. This positioning allows Linde to benefit from sustained price increases without significant spot sales exposure, creating a low-risk, high-confidence avenue for margin expansion. The helium dynamic, combined with the company's history of raising dividends for 33 consecutive years and disciplined capital allocation, supports a bullish case where underlying pricing power in specialty gases drives sustained EPS growth beyond the guided 7%-9% range, particularly if geopolitical supply constraints persist.
  • Linde plc's capital allocation model and fortress balance sheet provide a hidden catalyst for shareholder returns that the market is overlooking amid macroeconomic uncertainty. With $900 million of free cash flow generated in Q1 after $1.3 billion in capital expenditures, the company deployed $800 million in share repurchases and raised dividends by 7%, maintaining a consistent return of capital to shareholders. Management emphasized that in periods of volatility, a strong balance sheet enables capitalizing on repurchase opportunities, and the return on capital remained at 23.8%, reflecting sustained capital discipline. This approach, combined with the company's ability to reinvest almost $1.5 billion into the business while returning capital, suggests that Linde can compound shareholder value even without top-line volume growth, as evidenced by 30% operating margins and 50 basis points of sequential margin improvement driven by pricing and productivity—not cyclical recovery—making the current valuation potentially attractive relative to its compounding capacity.
▼ Bear case
  • Linde plc faces persistent structural headwinds in EMEA that management is not adequately addressing, with CFO Matthew White acknowledging negative volumes from on-site customers shifting production to more competitive assets outside Continental Europe due to the Middle East conflict and weaker industrial activity. Despite noting some Latin American upstream improvements, the company admitted it is "not happy with the performance" in EMEA and expects only potential future improvements, not a near-term recovery. This regional weakness, which offsets growth in Americas and APAC, is exacerbated by energy price volatility and cost inflation that management concedes are being managed through surcharges rather than sustainable price increases, indicating a lack of true pricing power in the region. The reliance on surcharges—which fluctuate with energy volatility—creates earnings instability and undermines the quality of margin expansion, suggesting that reported operating margin improvements may be temporary and not reflective of sustainable operational strength in a key geographic segment.
  • The company's guidance explicitly assumes no economic improvement at the midpoint, revealing a lack of confidence in a broad-based industrial recovery that could undermine future growth prospects. Management repeatedly cited lingering industrial demand stagnation, weak industrial activity from geopolitical volatility, and the need for government engagement to support capital-intensive projects, indicating that Linde's growth is increasingly dependent on niche, high-intensity end markets like electronics and space rather than broad industrial recovery. This dependence raises concerns about scalability, as segments like healthcare (16% of sales) showed only 1% growth with US home care flat due to policy changes, and food and beverage (9% of sales) grew 5% but remains sensitive to consumer trends. Without a meaningful rebound in traditional industrial end markets—which constitute two-thirds of sales—Linde's ability to sustain 7%-9% EPS growth may be overstated, particularly if project backlog execution faces delays or if high-growth segments like electronics face cyclical downturns in semiconductor demand.
  • Linde plc's capital expenditure intensity and free cash flow conversion pose a hidden risk to shareholder returns, with $1.3 billion in capex consuming $2.2 billion of operating cash flow to generate only $900 million of free cash flow in Q1—a conversion rate of just 41%. While management highlighted disciplined allocation between dividends, repurchases, and reinvestment, the high base capex requirements (described as maintenance and smaller growth projects) suggest that a significant portion of cash flow is perpetually recycled into the business just to maintain current operations, limiting true excess cash available for shareholder returns. This dynamic is exacerbated by the company's reliance on project backlog execution for growth, with CFO White admitting that engineering business timing creates a "drag" on EPS growth, and the need to "get through" internal projects that are capitalized versus external profit-generating ones. If backlog projects face delays—as hinted at with the Woodside project's ATR and TNS slipping into Q1 next year—or if maintenance capex remains elevated due to aging infrastructure, free cash flow could remain constrained, undermining the sustainability of dividend growth and share repurchases despite the company's 33-year dividend increase streak.

Geographical Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Specialty Chemicals
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 LIN Linde Plc 237.95 Bn33.526.8724.68 Bn
2 SHW Sherwin Williams Co 78.17 Bn30.073.2711.70 Bn
3 ECL Ecolab Inc. 76.02 Bn30.014.738.24 Bn
4 APD Air Products & Chemicals, Inc. 66.38 Bn47.145.3317.40 Bn
5 PPG Ppg Industries Inc 26.02 Bn3,717.411.617.83 Bn
6 LYB LyondellBasell Industries N.V. 22.51 Bn-28.530.7611.45 Bn
7 SQM Chemical & Mining Co Of Chile Inc 19.70 Bn21.773.724.79 Bn
8 IFF International Flavors & Fragrances Inc 19.51 Bn-102.161.815.82 Bn